1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SHUTTLE PHARMACEUTICALS HOLDINGS INC
Shuttle Pharmaceuticals Holdings Inc
XNAS: SHPH
Download real time
5.33-0.22(-3.96%)
1302.63% Gain from 52W Low
28,970
XNAS Volume
High vol.+gain this week

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Shuttle Pharma Holdings Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Shuttle Pharma Holdings Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Shuttle Pharma Holdings Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit Shuttle Pharma Holdings Inc Jun-2026 Quarterly Net Profit is $-3 Million which is growth of 15.1% YoY.

Shuttle Pharmaceuticals Holdings Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
-42.22.82.33.931.83.11.51.41.31.61.5
Operating Profit
-4-2.2-2.8-2.3-3.9-3-1.8-3.1-1.5-1.4-1.3-1.6-1.5
⌄
-0-0-0-0-0-0.2-0.3-0.4-0.5-0.5-0.6-0.7
Profit Before Tax
-3.2-2.2-2.6-2.4-3.7-3.1-1.6-3.8-2-1.7-1.6-1.8-2.2
Tax
------------
⌄
-3.2-2.2-2.6-2.4-3.7-3.1-1.6-3.8-2-1.7-1.6-1.8-2.2
Diluted NI Avail to Com Stockholders Ann.
-3.2-2.2-2.6-2.4-3.7-3.1-1.6-3.8-2-1.7-1.6-1.8-2.2
Basic EPS
-3.1-4.3-12.9-10.5-32.9-75-98-397.5-240-200-200-220-300
Diluted EPS After ExtraOrdinary
--4.5-14.2-10.5-33-75.1-111.2-349-224.3-215.7-219-272-299.2
Number Of Shares End
10.50.20.20.100000000
Net Income Continuing Discontinued Operations
-3.2-2.2-2.6-2.4-3.7-3.1-1.6-3.8-2-1.7-1.6-1.8-2.2
Normalized Income
-4-2.2-2.9-2.4-3.7-3.1-1.8-3.3-1.9-1.9-1.8-2.2-2.2
Interest Income
00000
Interest
-000000.20.30.40.50.50.60.7
Net Interest Income
--0-0-0-0-0-0.2-0.3-0.4-0.5-0.5-0.6-0.7
EBIT
-3.2-2.1-2.6-2.3-3.7-3-1.4-3.5-1.6-1.2-1.1-1.2-1.5
EBITDA
-2.5-1.5-2.3-2.3-3.7-3-1.4-3.5-1.6-1.2-1.1-1.2-1.5
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
-0.60.3
Profit From Continuing Operations
-3.2-2.2-2.6-2.4-3.7-3.1-1.6-3.8-2-1.7-1.6-1.8-2.2
Normalized EBITDA
--1.6-2.6-2.3-3.7-3-1.7-3.1-1.5-1.4-1.3-1.6-1.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Shuttle Pharma Holdings Inc competitor comparison and performance snapshot within industry

Shuttle Pharma Holdings Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue Shuttle Pharma Holdings Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Annual Net Profit Shuttle Pharma Holdings Inc Annual Net Profit is $-12 Million which is growth of -28.2% YoY.

Shuttle Pharmaceuticals Holdings Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20
⌄
-
-
 
Cost Of Rev. Ann.
-
-
 ------
Gross Profit Ann.
-
-
 ------
Operating Exp. Ann.
66%
88.5%
3.311.97.75.92.61.70.5
Operating Profit Ann.
-
-
-11.2-11.9-7.7-5.9-2.6-1.7-0.5
⌄
-
-
-0-0.1-1.3-2.5-1-0.1-0
Other Exp. Ann.
-15.7%
-
 0.3-0.11.80.50.6-0.3
PBT Ann.
-
-
-10.3-11.7-9.1-6.6-3-1.2-0.8
Tax Ann.
-
-
 ---
⌄
-
-
-10.3-11.7-9.1-6.6-3.1-1.3-0.9
Diluted NI Avail to Com Stockholders Ann.
-
-
-10.3-11.7-9.1-6.6-3.1-1.3-0.9
EPS Ann.
-
-
 -71.6-797.5-880-580-188-136.9
Diluted EPS Ann.
-
-
 -71.6-825-880-580-188-136.9
Number Of Shares End
-
-
 0.20000-
Total Exp. Ann.
66%
88.5%
 11.97.75.92.61.70.5
Net Income Continuing Discontinued Operations Ann.
-
-
-10.3-11.7-9.1-6.6-3-1.2-0.8
Normalized Income Ann.
-
-
-11.4-12-8.9-8.4-3.5-1.8-0.6
Interest Income Ann.
-
-
000.1---
Interest Ann.
-53.6%
-
 0.11.42.510.10
EBITDA Ann.
-
-
-8.7-11.4-7.8-4.1-2-1-0.7
Reconciled Cost Of Rev. Ann.
-
-
 ------
Reconciled Depr. Ann.
44.2%
24.6%
 0.3000.10.10.1
Profit From Continuing Operations Ann.
-
-
-10.3-11.7-9.1-6.6-3-1.2-0.8
Normalized EBITDA Ann.
-
-
 -11.6-7.5-5.9-2.5-1.7-0.5
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
54.5%
2Y CAGR
42%
3Y CAGR
66%
5Y CAGR
88.5%
Operating Expenses Annual Cr growth is lower than historical averages.

Shuttle Pharma Holdings Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Shuttle Pharma Holdings Inc Dec-2025 Total Shareholders Fund is $2 Million which is growth of 217.9% YoY.

  • POSITIVE

    Total Assets Shuttle Pharma Holdings Inc Dec-2025 Total Assets is $10 Million which is growth of 318.0% YoY.

Shuttle Pharmaceuticals Holdings Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20
⌄
6.5%
83.8%
10.52.568.70.70.5
⌄
101.7%
30.1%
8.21.81.912.32.2
⌄
-33.2%
-
2.30.74.17.7-1.6-1.7
Total Capitalization Ann.
-33.2%
-
2.30.74.27.7-1.6-1.7
Tangible Assets Ann.
-
-
-7.60.74.17.7-1.6-1.7
Working Capital Ann.
-
-
-7.50.74.67.6-1.7-1.8
Invested Capital Ann.
-35.1%
-
2.31.64.88.4-0.8-1.1
Tangible Book Value Ann.
-
-
-7.60.74.17.7-1.6-1.7
Borrowings Ann.
-37%
-24.2%
0.21.21.10.810.8
Net Debt Ann.
-
-
----0.30.5
Share Issued Ann.
-
-
0.200000
Number Of Shares End
-
-
0.20000-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
320%
2Y CAGR
32.3%
3Y CAGR
6.5%
5Y CAGR
83.8%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
433.3%
2Y CAGR
182.8%
3Y CAGR
100%
5Y CAGR
30.7%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
228.6%
2Y CAGR
-25.1%
3Y CAGR
-33.2%
Total ShareHolders Funds Annual growth is higher than historical averages.

Shuttle Pharma Holdings Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Shuttle Pharma Holdings Inc Book Value Per Share is $4 which is growth of -88.1% YoY.

  • NEUTRAL

    ROE Shuttle Pharma Holdings Inc ROE is 0% which is growth of 0% YoY.

Shuttle Pharmaceuticals Holdings Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20
RoA Ann. %
-
-
--216.24%-90.28%-66.62%-209.95%-167.04%
ROE Ann. %
-
-
--383.84%-112.37%-102.47%--
ROIC %
-
-
---19.3-8.4--
OPM Ann. %
-
-
------
Inventory Turnover Ratio Ann.
-
-
------
Asset Turnover Ann. %
-
-
------
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-
-
-1.35.38.60.20.2
Current Ratio Ann.
-
-
-1.45.48.80.20.2
Interest Coverage Ratio Ann.
-
-
--5.7-1.7-2.1-21.7-19.3
LT Debt To Equity Ann.
-
-
-0.30.1---
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Shuttle Pharma Holdings Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Shuttle Pharma Holdings Inc Cash From Operating Activity is $-9 Million which is growth of -29.4% YoY.

  • NEGATIVE

    Net Cash Flow Shuttle Pharma Holdings Inc Net Cash Flow is $-2 Million which is growth of -141.7% YoY.

Shuttle Pharmaceuticals Holdings Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20
⌄
-
-
-9.5-7.3-5.6-2.7-0.3-0
⌄
-
-
-3.12.9-2.8--0
⌄
1.2%
156%
113.82.610.60.70.1
Cash Plus Cash Eqv. End Of Year Ann.
-67.1%
24.6%
0.31.92.68.40.50.1
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-1.6-0.7-5.87.90.40
Cash Plus Cash Eqv. Begin Of Year Ann.
56%
80.2%
1.92.68.40.50.10.1
Income Tax Paid Supplemental Data Ann.
-
-
--
Interest Paid Supplemental Data Ann.
-
-
0.10.10.20
Capex Ann.
-
-
-3.1--0---0
Issuance Of Capital Stock Ann.
-1.7%
-
9.5410--
Issuance Of Debt Ann.
12.6%
-
13.90.70.70.1
Repayment Of Debt Ann.
-
-
-0.2-0.9-1-0.1--
Repurchase Of Capital Stock Ann.
-
-
------
Free Cash Flow Ann.
-
-
-12.5-7.3-5.6-2.7-0.3-0
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
189.5%
2Y CAGR
105.7%
3Y CAGR
1.2%
5Y CAGR
156%
Cash from Financing Annual Activity growth is higher than historical averages.
×